Company performance
Add to research
Current Price
as of Mar 25, 2025$7.79
P/E Ratio
N/A
Market Cap
$614.28M
Description
Add to research
MeiraGTx Holdings Plc engages in the development of novel gene therapy treatments. It focuses on the development and manufacturing of genetic medicines to treat both inherited and more common conditions with severe unmet need. The company was founded on March 20, 2015 and is headquartered in New York, NY.
Metrics
Add to research
Overview
- HQNew York, NY
- SectorHealth Technology
- IndustryBiotechnology
- TickerMGTX
- Price$7.79+1.30%
Trading Information
- Market cap$614.28M
- Float67.23%
- Average Daily Volume (1m)796,640
- Average Daily Volume (3m)462,236
- EPS-$2.12
Company
- Revenue$33.28M
- Rev growth (1yr)137.42%
- Net income-$147.79M
- Gross margin-10.04%
- EBITDA margin-454.89%
- EBITDA-$151.38M
- EV$406.36M
- EV/Revenue12.21
- P/EN/A
- P/S16.34
- P/B9.00
- Debt/Equity125.02
Documents
Add to research
SEC Filings
Factset